If the drug covered by insurance isnt effective for that patient, there are usually no other drug options left, he said
However, the incidence of hypoglycemia was low in both treatments, indicating a favorable safety profile [1]
Medicare coverage for GLP-1 medications is currently very limited unless you have a diagnosis thats not related to weight loss, says Dave Knapp, founder of On the Pen , a community education website about GLP-1s
Levocarnitine is an amino acid derivative that plays a key role in energy production and fatty acid metabolism
Notably, a prescription that identifies only a patients name and drug product formulation is not sufficient to establish that the prescriber made the determination that the formulation would produce a significant difference from the commercially available drug product. According to the guidance, appropriate justification and documentation might include the following: No Dye X, patient allergy (if the comparable drug contains the dye) Liquid form, patient cant swallow tablet (if the comparable drug is a tablet) 6 mg, patient needs higher dose (if the comparable drug is only available in 5 mg dose)
Obesity and metabolic syndrome are significant contributors, with 54% of symptomatic patients under 30 showing elevated cholesterol and triglyceride levels
